UK markets close in 6 hours 46 minutes

National Health Investors, Inc. (WX6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
66.000.00 (0.00%)
As of 08:05AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.87B
Enterprise value 3.90B
Trailing P/E 23.67
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.82
Price/book (mrq)2.51
Enterprise value/revenue 13.39
Enterprise value/EBITDA 16.62

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 335.71%
S&P500 52-week change 322.23%
52-week high 367.00
52-week low 345.00
50-day moving average 361.73
200-day moving average 353.97

Share statistics

Avg vol (3-month) 38
Avg vol (10-day) 320
Shares outstanding 543.42M
Implied shares outstanding 646.86M
Float 843.92M
% held by insiders 14.62%
% held by institutions 164.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43.36
Forward annual dividend yield 45.09%
Trailing annual dividend rate 33.60
Trailing annual dividend yield 35.45%
5-year average dividend yield 46.49
Payout ratio 4118.03%
Dividend date 3N/A
Ex-dividend date 428 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 41.33%
Operating margin (ttm)62.55%

Management effectiveness

Return on assets (ttm)4.42%
Return on equity (ttm)10.24%

Income statement

Revenue (ttm)319.68M
Revenue per share (ttm)7.37
Quarterly revenue growth (yoy)-11.70%
Gross profit (ttm)N/A
EBITDA 247.22M
Net income avi to common (ttm)132.03M
Diluted EPS (ttm)2.79
Quarterly earnings growth (yoy)-11.70%

Balance sheet

Total cash (mrq)32.54M
Total cash per share (mrq)0.71
Total debt (mrq)1.43B
Total debt/equity (mrq)92.14%
Current ratio (mrq)0.83
Book value per share (mrq)33.73

Cash flow statement

Operating cash flow (ttm)194.23M
Levered free cash flow (ttm)171.54M